Published in Biotech Business Week, September 22nd, 2003
Aspect has standardized production and related systems on the QAD platform. By upgrading to MFG/PRO eB2, the manufacturer anticipates that real-time access to data will help improve inventory management and related customer support, as well as help streamline financials for global operations.
Aspect pioneered the first clinically proven and commercially available direct measure of the effects of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.